UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011459
Receipt number R000013414
Scientific Title Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)
Date of disclosure of the study information 2013/08/12
Last modified on 2019/08/19 16:12:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)

Acronym

Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)

Scientific Title

Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)

Scientific Title:Acronym

Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)

Region

Japan


Condition

Condition

Colorectal Cancer

Classification by specialty

Surgery in general Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the correlation of a clinical response and a clinicopathologic factor and search for a recurrence prediction factor.

Basic objectives2

Others

Basic objectives -Others

Searches of the recurrence prediction factor.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Correlation of a clinical response and a clinicopathologic factor.

Key secondary outcomes

Correlation of Dose Intensity and Relapse Free Survival.
Safety


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Histologically confirmed colorectal cancer
2. High risk stage II or stage III
3. Curability A surgery
4. Age >= 20 years
5. ECOG performance status of 0-1
6. Treatment plan of XElOX adjuvant therapy
7. Adequate organ function
8. Signed written informed consent

Key exclusion criteria

1. Prior oxaliplatin therapy
2. Prior chemotherapy or radiotherapy for colorectal cancer
3. Brain metastasis or active multiple malignancy
4. Peripheral nerve disorder
5. A history of severe drug allergy
6. Active infectious disease
7. Significant mental illness
8. Following complications
i) Uncontrolled diabetes
ii) Uncontrolled hypertension
iii) Interstitial pneumonia
iv) Iintestinal tract paralysis or ileus
v) Significant heart trouble
9. Inadequate for study enrollment by the physician

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Masayoshi
Middle name
Last name Nakanishi

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Surgery Division of Digestive Surgery

Zip code

602-8566

Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan

TEL

075-251-5527

Email

mnakan@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Masayoshi
Middle name
Last name Nakanishi

Organization

Kyoto Prefectural University of Medicine

Division name

Division of Digestive Surgery

Zip code

602-8566

Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan

TEL

075-251-5527

Homepage URL


Email

mnakan@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine
Department of Surgery
Division of Digestive Surgery

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto Prefectural University of Medicine

Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan

Tel

075-251-5527

Email

mnakan@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都府立医科大学病院
京都第二赤十字病院
京都第一赤十字病院
大阪鉄道病院
松下記念病院
済生会滋賀県病院
明石市立市民病院
社会保険京都病院
社会保険神戸中央病院
京都府立医科大学付属北部医療センター
公立南丹病院
近江八幡市立総合医療センター
済生会京都府病院
綾部市立病院
市立奈良病院
市立福知山病院
愛生会山科病院
国立舞鶴医療センター
京都山城総合医療センター
西陣病院
京都きづ川病院
第二岡本総合病院
堀川病院
亀岡市立病院
北出病院
京都九条病院
洛西ニュータウン病院
舞鶴赤十字病院
六地蔵病院


Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

251

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 24 Day

Date of IRB

2013 Year 07 Month 26 Day

Anticipated trial start date

2013 Year 08 Month 12 Day

Last follow-up date

2019 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Clinical Response
Clinicopathologic Factor
Adverse Event


Management information

Registered date

2013 Year 08 Month 12 Day

Last modified on

2019 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013414